
The UK’s competition watchdog has threatened Groupon with court action if the deals site does not quickly “improve its treatment of customers.”
The Competition and Markets Authority (CMA) announced on Monday, August 9, that an investigation into Groupon has found evidence the website – which offers everything from garden furniture to discounted haircuts and experience days – does not always give customers cash refunds, seeing some instead as “only offered Groupon credits.”
The regulator also stated that it has concerns the company is failing to deliver all its products within the timeframes it advertises, and is failing to ensure that its descriptions of its offerings are accurate.
The CMA also stated it is concerned Groupon is not making sure the goods it sells “are of a satisfactory quality.”
CMA chief executive, Andrea Coscelli, said, “More people than ever are shopping online, especially over the last year. It is therefore essential that online businesses treat customers fairly and refund them money where due under consumer law.
“Groupon must swiftly step up and do right by its customers if it wants to avoid court action.”
It is not the first time the CMA – formerly known as the Office of Fair Trading – has probed Groupon. The first was in 2012, when the OFT raised concerns about “unfair and misleading pricing practices.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas